Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F X Jarreau

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Heart Journal|December 1, 1984
A new inotropic aminosteroid: LND 623F X Jarreau, J J Koenig, S Fenard
Annales Pharmaceutiques Francaises|January 1, 1971
[Apropos of a falsification of Strophantus gratus Franchet seeds. A new alkaloid, alafine, isolated from Alafia sp. seeds and from Alafia multiflora Stapf (Apocynaceae)]M Païs, F X Jarreau, P Fouché, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitorV Rovei, D Caille, O Curet, et al.
Planta Medica|June 1, 1988
Growth and digoxin content in Digitalis lanata in controlled conditions and natural environmentC Brugidou, M Jacques, L Cosson, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum monoamines in freely moving ratsO Curet, G Damoiseau, J P Labaune, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profileO Curet, G Damoiseau, N Aubin, et al.
Fundamental & Clinical Pharmacology|January 1, 1989
Comparative hemodynamic study of a new aminosteroid: LND-623 with its 20 alpha-isomer: LND-369, and with digoxin and digoxigenin-rhamnoside in the anesthetized dogJ Weissenburger, J Heckle, M Biour, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1983
[Comparison of the cardiac electrophysiologic effects of quinidine, 3-hydroxyquinidine and 3-hydroxyhydroquinidine in the anesthesized dog. Study of plasma dose response relations]J M Juliard, J Heckle, P Jaillon, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzymeJ Wouters, F Moureau, D P Vercauteren, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profileD Caille, O E Bergis, C Fankhauser, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Heart Journal|December 1, 1984
A new inotropic aminosteroid: LND 623F X Jarreau, J J Koenig, S Fenard
Annales Pharmaceutiques Francaises|January 1, 1971
[Apropos of a falsification of Strophantus gratus Franchet seeds. A new alkaloid, alafine, isolated from Alafia sp. seeds and from Alafia multiflora Stapf (Apocynaceae)]M Païs, F X Jarreau, P Fouché, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitorV Rovei, D Caille, O Curet, et al.
Planta Medica|June 1, 1988
Growth and digoxin content in Digitalis lanata in controlled conditions and natural environmentC Brugidou, M Jacques, L Cosson, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum monoamines in freely moving ratsO Curet, G Damoiseau, J P Labaune, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profileO Curet, G Damoiseau, N Aubin, et al.
Fundamental & Clinical Pharmacology|January 1, 1989
Comparative hemodynamic study of a new aminosteroid: LND-623 with its 20 alpha-isomer: LND-369, and with digoxin and digoxigenin-rhamnoside in the anesthetized dogJ Weissenburger, J Heckle, M Biour, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1983
[Comparison of the cardiac electrophysiologic effects of quinidine, 3-hydroxyquinidine and 3-hydroxyhydroquinidine in the anesthesized dog. Study of plasma dose response relations]J M Juliard, J Heckle, P Jaillon, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzymeJ Wouters, F Moureau, D P Vercauteren, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profileD Caille, O E Bergis, C Fankhauser, et al.
Pageof 2